Onco Access
About
What does Onco Access do?
OncoAccess aims to accelerate cancer research by connecting patients with relevant clinical trials. Their platform helps oncologists and researchers identify suitable trials, streamline patient enrollment, and improve access to innovative treatments. They focus on simplifying the complex process of clinical trial participation for both healthcare providers and patients.
Where is Onco Access headquartered?
Onco Access is headquartered in New York, United States.
When was Onco Access founded?
Onco Access was founded in 2023.
What industry does Onco Access operate in?
Onco Access operates in HealthTech, MedTech, Clinical Trials, Drug Discovery, Oncology, Patient Access.
What is Onco Access's current status?
Onco Access's current operating status is: Inactive.
AI-powered platform for healthcare providers to manage patient WhatsApp messages efficiently.
AI-powered platform for personalized weight management and health coaching.
Clinical Trial Discovery by ENSCORE.
An independent research reference providing accessible, accurate, and transparent information on bioactive peptides and peptide science.
Medbytes provides doctors with a personalized platform for high-impact medical research and news in their specialty.
SYLARIS™ offers premium wearable wellness patches and clinical-grade skincare designed for effortless, intentional, and beautifully designed self-care rituals.
Provider-supervised peptide therapy, NAD+ support, and cognitive enhancement for cellular renewal, recovery, and healthy aging.
Purpose-built WordPress plugins for healthcare and the agencies that serve them.
An entrant is a company tagged HealthTech whose domain was first registered in the window, counted from registry records in the StartupHub directory. 6 of them registered in the last 30 days. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
No comments yet. Be the first to share your take.